Kimberlee C. Drapkin

Chief Financial Officer, EPIX Pharmaceuticals, Inc.

Companies

Climb Bio, Inc.Board member Apr 1, 2025 to now¹
LENZ Therapeutics, Inc.Board member Aug 1, 2023 to now²
Acumen Pharmaceuticals, Inc.Board member Apr 4, 2022 to now³
Proteostasis Therapeutics (United States)Board member Feb 5, 2019 to now⁴
Jounce TherapeuticsPresident May 4, 2023 to May 4, 2023⁵
Jounce TherapeuticsChief financial officer Jan 26, 2017 to May 4, 2023⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARClimb Bio, Inc., Board member
2
SEC EDGARLENZ Therapeutics, Inc., Board member
3
SEC EDGARAcumen Pharmaceuticals, Inc., Board member
4
SEC EDGARProteostasis Therapeutics (United States), Board member
5
SEC EDGARJounce Therapeutics, President
6
SEC EDGARJounce Therapeutics, Chief financial officer